Sandra and Edward Meyer Cancer Center

News

Photo of Linda Vahdat, M.D.

2016 Dec 28

Breast center launches innovative crowdfunding campaign to fund clinical trial

Linda Vahdat, M.D., is turning to the public to help fund a trial for a new triple negative breast cancer treatment involving a simple oral medication that reduces copper levels in the patient’s body Read more

Jeffrey Greenfield, M.D., Ph.D.

2016 Dec 24

The profound impacts of patients

Jeffrey Greenfield, M.D., Ph.D., shared his story about how one patient had a profound impact on his career. Read more

Neurosurgeon Theodore Schwartz, M.D.

2016 Dec 22

7 Warning Signs Of A Brain Tumor You Should Know

Neurosurgeon Theodore Schwartz, M.D., shares some brain tumor symptoms. Read more

Photo of Dr Fine

2016 Dec 21

Metabolic pathways may provide opportunity for novel therapeutic targeting in neuro-oncology

Howard Fine, M.D., discusses the investigation of metabolic pathways in brain tumors to identify potential new therapeutic targets. Read more

Photo of Dr Samie Jaffrey

2016 Dec 21

Research reveals codes that control protein expression

An internal code in messenger RNA predetermines how much protein they will produce, according to a new study by Samie Jaffrey. Read more

Holly Prigerson, Ph.D.

2016 Dec 20

End-of-life discussions held at ‘astounding’ infrequency

Ninety-five percent of patients with advanced cancer have an insufficient understanding of their prognosis and are ill-equipped to make informed end-of-life care decisions, according to a study by Holly Prigerson, Ph.D., and colleagues. Read more

Robert Brown, M.D., liver transplant doctor at Weill Cornell New York Presbyterian

2016 Dec 20

New model could benefit liver cancer transplant patients

A simple blood test may better predict which patients diagnosed with liver cancer will experience disease recurrence, according to new research from Weill Cornell Medicine doctors. Read more

Photo of Olivier Elemento

2016 Dec 16

New guidelines aim to standardize interpretation and reporting of somatic cancer variants

Olivier Elemento, Ph.D., comments on a new set of guidelines released by the Association for Molecular Pathology. Read more

Photo of Dr. Shahin Rafii

2016 Dec 15

Corrupted tumor blood vessels spawn cancer stem cells

The tumor microenvironment can determine whether cancer cells become aggressive cancer stem cells that are resistant to treatment and cause cancers to come back after therapy, according to a new study by a team of researchers led by Shahin Rafii. Read more

Photo of Dr. Harold Varmus

2016 Dec 13

NYC biotech industry to get big boost from new de Blasio initiative

Harold Varmus, M.D., was named as co-chair of a new Life Sciences Advisory Council for the city of New York Read more

Photo of Dr Varmus

2016 Dec 12

The Cancer Lottery

Harold Varmus, M.D., discusses some of the "lost opportunities" in cancer genomics. Read more

Gastrointestinal oncologist Allyson Ocean of the Meyer Cancer Center

2016 Dec 10

Greater collaboration may improve outcomes in pancreatic cancer

Two recent features highlighted the efforts of Allyson Ocean, M.D., to involve patients in their treatments for pancreatic cancer. Read more

Photo of Linda Vahdat, M.D.

2016 Dec 09

Vahdat presents promising new treatment for triple negative breast cancer

Linda Vahdat, M.D., MBA, presented promising results of the use of IMMU-132 to treat triple-negative breast cancer. Read more

Kristy Richards, M.D., Ph.D.

2016 Dec 09

The P.A.Th. to better models

Researchers at Weill Cornell Medicine and the Cornell University College of Veterinary Medicine have undertaken an ambitious $5 million project to create new model systems that accurately reflect the biology, genetics and tumor-host interactions of difficult-to-treat blood cancers. Read more

Weill Cornell hematology experts were well represented at ASH conference

2016 Dec 09

Hematologists present research at 2016 ASH conference

Thousands of hematologists gathered in San Diego on Dec. 3 for the 58th Annual Meeting of the American Society of Hematology (ASH), and Weill Cornell Medicine/NewYork-Presbyterian was well represented. Read more

Jim Hu, M.D.

2016 Dec 07

Infections after prostate biopsy continue to rise

Infectious complication rates following prostate biopsies continue to increase, despite decreased use of the procedures, according to Jim Hu, M.D. Read more

Manish Shah, M.D., gastrointestinal oncology expert at the Meyer Cancer Center of Weill Cornell Medicine

2016 Nov 28

Treating advanced gastroesophageal cancers

Manish Shah, M.D., discusses aspects of treating gastroesophagael cancers, including molecular testing and multidisciplinary management. Read more

Mingming Wu, Ph.D

2016 Nov 21

Cancer cells 'talk' to their environment, and it talks back

A multidisciplinary team led by Ithaca member Mingming Wu has devised a method for measuring the force a breast cancer cell exerts on its fibrous surroundings. Read more

Photo of Dr Fine

2016 Nov 19

Therapeutic Metabolic Targets in Brain Cancer

Howard Fine, M.D., discusses the importance of novel metabolic targets, such as IDH mutations, in the field of neuro-oncology. Read more

Dan Landau and Marcin Imielinski

2016 Nov 18

Tracing Cancer’s Roots

Marcin Imielinski, M.D., Ph.D., and Dan Avi Landau, M.D., Ph.D, are using genomics to better understand—and combat—tumors. Read more